This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Dihydrocodeine: Difference between revisions
Jump to navigation
Jump to search
>Rhz m Text replacement - "(\|)([A-Za-z]+)ROA_Light=[ ]*([0-9.]+)[- ]+([0-9.]+)[ ]*([muµ]g)" to "$1$2ROA_Light=$2 light min dose::$3 - $2 light max dose::$4 $5" |
>Isaak Common names correctly annotated. |
||
| (15 intermediate revisions by 8 users not shown) | |||
| Line 1: | Line 1: | ||
{{SubstanceBox | {{SubstanceBox | ||
<!-- | <!-- Special Parameters --> | ||
|MaterialTable_MaxWidth= | |displayClasses={{{displayClasses|}}} | ||
|MaterialTable_MaxWidth=250px | |||
|MaterialTable_Title={{PAGENAME}} | |MaterialTable_Title={{PAGENAME}} | ||
| Line 32: | Line 33: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption= | |MolecularStructureCaption=Molecular structure of dihydrocodeine | ||
|SkeletalImageFile=File: | |SkeletalImageFile=File:Dihydrocodeine.svg | ||
|SkeletalImageWidth= | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
|3DImageWidth= | |3DImageWidth=245px | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=Dihydrocodeine | |NameCommon=[[common name::Dihydrocodeine]] | ||
|NameSubstitution= | |NameSubstitution= | ||
|NameSystematic=4,5-alpha-epoxy-3-methoxy-17-methylmorphinan-6-ol | |NameSystematic=4,5-alpha-epoxy-3-methoxy-17-methylmorphinan-6-ol | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[Opioid]] | |EffectClass=[[Psychoactive class::Opioid]] | ||
|ChemicalClass=[[Morphinan]] | |ChemicalClass=[[Chemical class::Morphinan]] | ||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
| Line 53: | Line 54: | ||
|OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation.<br>'''This dosage and duration information has been sourced from [http://drugs.tripsit.me/dihydrocodeine TripSit]''' | |OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation.<br>'''This dosage and duration information has been sourced from [http://drugs.tripsit.me/dihydrocodeine TripSit]''' | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose::20]] | |OralROA_Threshold=[[Oral threshold dose::20]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral light | |OralROA_Light=[[Oral min light dose::50]] - [[Oral max light dose::100]] mg | ||
|OralROA_Common=[[Oral min common dose::100]] - [[Oral max common dose::150]] mg | |OralROA_Common=[[Oral min common dose::100]] - [[Oral max common dose::150]] mg | ||
|OralROA_Strong=150 - 200 mg | |OralROA_Strong=[[Oral min strong dose::150]] - [[Oral max strong dose::200]] mg | ||
|OralROA_Heavy=[[Oral heavy dose::200]] mg + | |OralROA_Heavy=[[Oral heavy dose::200]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
| Line 64: | Line 65: | ||
|OralROA_Peak= | |OralROA_Peak= | ||
|OralROA_Offset= | |OralROA_Offset= | ||
| | |OralROA_Aftereffects= | ||
}} | }} | ||
Latest revision as of 23:56, 12 May 2022
| SubstanceBox/Dihydrocodeine | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||
| Common names | Dihydrocodeine | ||||||||||||||||||||||||
| Systematic name | 4,5-alpha-epoxy-3-methoxy-17-methylmorphinan-6-ol | ||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||
| Psychoactive class | Opioid | ||||||||||||||||||||||||
| Chemical class | Morphinan | ||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||